A Georgia Lawyer
A Georgia Lawyer Blog features forms, news, musings and commentary from a lawyer working for consumers and injured people. Mark Zamora, the author of this blog, is an attorney licensed in Georgia, with offices in Atlanta. He limits his practice to consumers.
Channels
- Practice Area
- Administrative Law
- Admiralty & Maritime Law
- Advertising Law
- Alternative Dispute Resolution
- AmLaw 200 Blogs
- Antitrust Law
- Bankruptcy
- Civil Rights & Privacy Law
- Consumer Law
- Corporate & Commercial Litigation
- Criminal Law
- Divorce & Family Law
- Education Law
- Election Law & Political Commentary
- Electronic Discovery
- Employment & Labor Law
- Environmental Law
- General Counsel Blogs
- Immigration Law
- Insurance Law
- Intellectual Property Law
- International Law
- Judiciary Law
- Media, Entertainment & Sports Law
- Law Firm Management & Legal Marketing
- Personal Injury & Medical Law
- Probate & Estate Planning
- Real Estate & Construction Law
- Tax & Financial Law
- Technology
- Whistleblower Law
- Workers' Compensation
- Law School
Recent Articles
Attorneys Mark Zamora (404-451-7781)and Joey James (256-764-0095) Dateline NBC Report
Our lawyers investigate claims of wrongdoing by companies whose products allegedly injure hard working consumers. Joey and I have known each other for more than 20 years, and we worked together investigating claims involving supplements and products. While we do our level best to right a...
Coconut Water Manufacturer Sued for False Label Claims
In a recently-filed lawsuit, Patrick J. Vital, a resident of the state of Florida, filed a class action complaint against One World Company, LLC (also known as One Natural Experience and doing business as One World Enterprises, LLC) for providing false information on the nutritional labels of their...
Kim Kardashian Faces Diet Pill Lawsuit
A lawsuit filed by four former QuickTrim customers, alleges Kardashian markets the products as being clinically shown to quicken the metabolism, curb the appetite, and promote weight loss. In reality, QuickTrim is nothing more than an expensive caffeine pill loaded with "gimmicky" ingredients...
March 2012 Pradaxa News for GA and FL
Pradaxa UsePradaxa is a blood thinning agent (anticoagulant) that is prescribed to reduce the risk of stroke in patients with non-valvular atrial fibrillation. Pradaxa is manufactured by Boehringer Ingelheim. The U.S. Food and Drug Administration, FDA, approved Pradaxa on October 19, 2010.FDA...
March 15, 2012 GA Mesh News
Many folks are seeing the term "POP" when they hear about mesh and mesh implants failing. Pelvic Organ Prolapse is commonly called POP - P is the condition that results when the normal supporting structures of the vagina deteriorate.The resultant support loss can cause any or all of the...
Social Media and the Law: Pinterest?
I was quoted in an article on Law.com's LTN. I'm not a big believer in down stream social media like Twitter (yet) or Google + (soon, maybe) as a way to get lawyers to gain a presence.For me, social media is still blogging and a good law website. Today's LTN has some quotes from me regarding...
3/14/12: DMAA will be banned in NZ?
A common ingredient in weight-loss and sports-performance supplements is to be banned in New Zealand after at least one user suffered a stroke.Associate Health Minister Peter Dunne this week used legislation brought in to combat synthetic cannabis products to ban the substance, commonly known as...
Gerber Good Start Gentle Formula Recall News
Gerber Products Company is retrieving and offering a replacement to consumers who purchased GerberĀ® Good StartĀ® Gentle powdered infant formula 23.2 ounce plastic package from batch GXP1684 expiration date of March 5, 2013.The product poses no health or safety risk. However, this product might...
FDA Says Warner Chilcott's Ovcon Contraceptive Pills At Risk
Here is the warning letter from the FDA and concerns about potency:Mr. Roger BoissonaultChief Executive OfficerWarner Chilcott Company, LLC100 Enterprise DriveRockaway, NJ 07866Dear Mr. Boissonault:During our June 22 to July 29, 2011 inspection of your pharmaceutical manufacturing facility, Warner...
$1 Billion Risperdal Settlement Rejected
From the WSJ:Federal prosecutors in Washington, D.C., have rejected a roughly $1 billion proposed settlement to resolve allegations that Johnson & Johnson promoted the antipsychotic drug Risperdal for unapproved uses, according to people familiar with the...

